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ABSTRACT  
A Possible luxR solo Type Regulator of an Antibiotic-Like Compound from the Soil Bacterium 
Rhodococcus 
by 
Katelyn Sellick  
 
Rhodococcus, a species of bacteria commonly found in the soil, is an under-explored producer of 
small bioactive compounds including siderophores, pigments and antibiotics. MTM3W5.2 is a 
strain of Rhodococcus that was previously discovered to produce an antibiotic-like compound 
that has inhibitory effects on other Rhodococcus strains, including the veterinary pathogen, R. 
equi. The biosynthetic gene cluster responsible for production of the antibiotic has been 
identified, and a small gene, BTZ20_3964 at the start of the operon is believed to be a luxR solo 
regulator of the gene cluster. The goal of this project was to determine this gene’s status as a 
regulator for the gene cluster. Merodiploids were constructed using the deletion construct, 
pEX18Km3964AD to obtain a double crossover recombination event to replace the functional 
gene with the deletion construct. However, evidence indicates that an illegitimate recombination 
event occurred to produce a merodiploid strain.  
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CHAPTER 1 
INTRODUCTION 
 
Antibiotic Resistance 
 Antibiotic resistance is an impending crisis in the health care field where antibiotics are 
no longer effective against many dangerous pathogens. There are critical health challenges 
associated with antibiotic resistant infections, such as longer hospital stays and more expensive 
treatments. Antibiotic resistance is where antibiotics are no longer effective against their targets 
due to some gene acquired by bacteria. Bacteria evolve rapidly and can acquire antibiotic 
resistance genes through conjugation, bacteriophage infection, transformation, or through 
spontaneous mutation. The mechanism of resistance varies with the gene and type of antibiotic, 
but can include mechanisms such as changing the antibiotic’s target, inactivating the antibiotic, 
or block access to the target molecule via changes in permeability or efflux pumps. (Giedraitienė 
et al. 2011). Table 1 shows types of antibiotics and the types of resistance mechanisms against 
the antibiotics The rise of antibiotic resistance is likely due to the overuse of antibiotics in 
agricultural and food industries, and the inappropriate use of antibiotics in health care such as the 
wrong antibiotic being prescribed, patients not taking them as directed, or when antibiotics are 
not needed and still prescribed. In 2013, the CDC estimated that at least 2 million people 
acquired an antibiotic resistant infection, and at least 23,000 of the patients died as a result of the 
infection. It was estimated that antibiotic resistant infections caused over $20 billion in excess 
direct health care costs (CDC 2013).  
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Table 1: Classes of Antibiotics and Mechanisms of Resistance (Kapoor et al. 2017). 
 
  
 
 
 
 
 
 
 
  
 Once a bacterium acquires an antibiotic resistance gene, the gene is often selected for and 
preserved even outside of antibiotic treatment because the gene sometimes provides some benefit 
to the bacterium, such as allowing them to survive other high stress situations (Berry et al. 2006). 
Many studies have determined that many water sources have low, nonlethal concentrations of 
antibiotics present which can place a low selective pressure for bacteria to maintain their 
resistance gene (Xi et al. 2009). In both humans and animals, a high percentage of antibiotics can 
be excreted in an unaltered state, so they are still active in wastewater and agricultural runoffs. 
Antibiotic resistant bacteria and antibiotic resistance genes are considered environmental 
Antibiotic Class Resistance type  
Aminoglycosides 
Antibiotic inactivation 
(Enzyme 
modification)  
  Decreased uptake  
Beta-Lactams 
Antibiotic inactivation 
(Enzyme degradation) 
  Altered PBP 
Chloramphenicol Antibiotic inactivation  
  Efflux pumps 
Glycopeptides Altered targets 
Macrolides Efflux pumps 
  Altered targets  
Tetracyclines Efflux pumps  
  Altered targets 
Sulfa drugs Altered targets  
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pollutants that can persist in aquatic and soil environments, contributing to the high levels of 
antibiotic resistance (Pruden et al. 2006). 
 As levels of antibiotic resistance continue to rise, rate of discovery of new antibiotics has 
slowed drastically, almost to a complete halt. The first true antibiotic, penicillin, was discovered 
by Alexander Fleming in 1928 though it was not available commercially until the 1940s (Quinn 
2013).  There are many different inhibitory molecules that are active against microbial 
pathogens, but a true antibiotic must have special properties: an antibiotic is selectively toxic to a 
microbial cell (usually a bacterium) but does not harm human cells or tissues. The antibacterial 
properties of penicillin revolutionized treatment of bacterial infections. By the end of World War 
II, many pharmaceutical companies were mass producing penicillin and working to discover 
more antibiotics as they quickly discovered antibiotic resistance developed within years of the 
release of new antibiotics. The first documented case of a penicillin-resistant E. coli strain 
occurred in 1940, and by 1945, Fleming predicted an “era of abuse” would occur due to the high 
demand for antibiotics (Lobanovska and Pilla 2017). If new antibiotics could not be found, a 
post-antibiotic era would come about and once treatable infections would become deadly again. 
14 
 
 
Figure 1: A timeline of discovery for novel antibiotics. Bolded classes are synthetic in origin, 
and normal font is natural in origin (Singh and Barrett 2006). 
 
Discovery of New Antibiotics 
  A “golden age” of antibiotic discovery occurred during the 1940s-1960s, with many new 
classes of antibiotics being discovered during this time. Penicillin was produced by a mold, 
Penicillium notaum, but many research efforts focused on prokaryotes in the production of 
inhibitory molecules (Singh and Barrett 2006). Traditionally, bacteria were cultured and 
screened for the presence of inhibitory compounds, but the issue was the high rediscovery rates. 
Compounds with similar structures and functions were re-isolated over and over, and the 
financial success dwindled. By the 1990s, half of the pharmaceutical companies abandoned their 
research in natural antibiotics and the remaining companies cut funding so antibiotic research 
accounted for less than 2% of overall research and development (Quinn 2013). Instead of 
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looking for naturally produced molecules, the pharmaceutical industry began to screen large 
libraries of chemically synthesized compounds. Indeed, the discovery of new molecules that bind 
to novel bacterial targets were discovered by this method,  but most of these new compounds fail 
to cross the bacterial cell wall and thus are not therapeutically useful (Wright 2018). Daptomycin 
was the last novel (i.e., binds to a novel bacterial target molecule) antibiotic discovered that has 
been approved for clinical use in the early 2000s and was the first new class of antibiotic in 
decades. Texiobactin is a new antibiotic that was discovered in 2015 that is produced by 
Eleftheria terrae and looks to be a promising treatment for MRSA, but is still in early trials and 
is not yet being used for clinical treatment (Arooj and Koh 2017).  
 Discovery of new antibiotics is challenging; traditionally bacteria are cultured and 
screened for inhibitory activity, but the problem with this is that it is predicted that less than 2% 
of known environmental bacteria can be cultured in typical laboratory growth conditions (Wade 
2002). Many bacteria might produce antibiotics, but cannot be cultured in a lab setting, so 
previously, there was no way to screen for antibiotic production in unculturable bacteria. Today, 
culture-free genomic sequencing of environmental samples can indicate the presence of 
biosynthetic gene clusters (BGCs), which could indicate a natural product may be produced by 
the microbe (Hover et al. 2018). The issue with this method is that many BGCs are 
uncharacterized and the function of their products are unknown. Secondly, it can be difficult to 
determine the function of these products if they are produced under a cryptic pathway, meaning 
they are not produced in vitro. Many bacteria may produce clinically useful products, but they 
may not be produced or detected under typical growth conditions, so awakening cryptic 
pathways in vitro may be beneficial in future searches for new antibiotics, so traditional culturing 
methods can only detect a small percentage of these small products. It is predicted that up to 90% 
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of small molecules that can be produced by bacteria remain unknown (Walsh and Fischbach 
2010). It is for this reason that many researchers have returned to searching for natural products 
in the search for new antibiotics. Rather than focusing on discovering new natural products 
produced in typical lab conditions, focus has shifted to methods to discover this unknown reserve 
of natural products such as turning on expression of cryptic genes in vitro, expression of 
environmental DNA (Kallifidas et al. 2012),  growing species in co-cultures (Molloy  and 
Hertweck 2017), and finding chemical elicitors to activate expression (Okada and 
Seyedsayamdost 2017).  
 
Expression of Antibiotics 
 Secondary metabolites are natural products (usually small organic molecules) that are 
produced by a microbe that are not essential to the growth or reproduction of the microbe, but 
may help the microbe compete and survive in a natural setting (Tyc et al. 2017). They include a 
variety of different products that can have a broad range of functions. Secondary metabolites 
include things such as siderophores, which help microbes acquire enough iron from the 
environment, pigments, toxins, and inhibitory molecules.  
 Natural products make up a large percentage of clinically used drugs including aspirin 
and morphine. Many of our clinically used antibiotics comes from the Actinobacteria family, 
such as from Streptomyces species. According to Elsayed et al. (2017), around 23,000 antibiotics 
have been discovered from microbes, and about 10,000 of those come from the members of the 
Actinomyces family. Culture-based studied have shown that many bacterial species can produce 
several secondary metabolites, but often do so under cryptic pathways; cryptic pathways may 
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control up to 90% of all metabolites (Tyc et al. 2017) (Walsh and Fischbach 2010). The reason 
for these cryptic pathways may be that secondary metabolites often cost a lot of energy and 
resources to produce, so having constant expression of the metabolites would be quite wasteful 
for the cell when they are not needed; for example, a species does not need to make antibiotics in 
an environment free of competitors.  
 One way that these genes required to produce antibiotics may be controlled is through a 
quorum-sensing system (QS), where microbes can “communicate” with each other and alter gene 
expression based on signals they receive from nearby cells. Bacteria may want to repress or 
activate transcription of certain metabolites based on the population density of neighboring cells, 
and quorum sensing is a way they can communicate to make a coordinated response to stimuli. 
In a typical QS system, such as the luxR system, transcription is controlled by a luxR type 
regulator protein. A luxI type synthase in the cell will produce an autoinducer molecule called 
acyl homoserine lactones (AHLs), which will bind to the luxR regulator, which will then alter 
gene expression by either repressing or activating transcription. This system is used to regulate 
processes such as virulence, motility, sporulation, production of a biofilm, and antibiotic 
production. Both Gram negative and Gram positive bacteria use QS systems, where AHLs are 
traditionally produced by the Gram negatives, and processed oligo-peptides are produced as the 
autoinducer in Gram positive cells. Gram positive bacteria use a two-component system where 
peptides are secreted by the cell and detected by a sensor kinase within the cell. The sensor 
kinase will initiate a phosphorylation cascade that will result in the phosphorylation of the 
response regulator, which can then bind DNA and adjust transcription of the regulated gene. 
Communication via autoinducers occurs both within and between bacterial species, so bacteria 
may also alter gene expression based off of signals they receive from another type of bacterium 
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in their vicinity. Many antibiotics produced by the Streptomyces species are known to be 
controlled under QS systems, so the bacteria only activate expression when they need to compete 
in their environment (Miller and Bassler 2001).  
 
luxR Solos 
 The luxR gene is usually adjacent to or in the proximity of the luxI gene on the 
chromosome, but some microbes have been characterized to have a luxR type regulator with no 
associated luxI gene on the operon. These are known as luxR solo regulators, where gene 
expression is controlled through other signals. These signals may be endogenous, produced by 
another luxI type synthase somewhere else in the genome, or exogenous, received from an 
external source or a non-AHL signal as shown in figure 2. luxR solos have been discovered to be 
widespread in Proteobacteria, but are not well characterized in other types of bacteria 
(Hudaiberdiev et al. 2015). 
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Figure 2: Possible mechanisms of a luxR solo regulator. (A) shows a typical luxR/ luxI system, 
(B) and (C) show where a luxR solo may receive their autoinducer signals. (Hudaiberdiev et al. 
2015) 
 
Rhodococcus 
 Rhodococcus is a member of the Actinobacteria phylum. It was first identified in 1891 by 
Zopf. The genus is commonly found in the soil, but it can also be found in other environments 
such as aquatic environments, in animal dung, and in insects and plants (Bell et al. 1998). 
Members of the genus are described as being Gram positive, aerobic, nonmotile and is a 
nocardioform, meaning they lack a set morphology, instead they form hyphae and break off into 
rods or cocci. The genome of Rhodococcus species are typically G-C rich.  
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 Rhodococcus has been shown to produce a variety of bioactive metabolites such as 
pigments, siderophores, and inhibitory compounds, but remains underexplored as a source of 
clinically used antibiotics. It is a relative of the Streptomyces genus, which also falls under the 
Actinobacteria phylum, which is known to be a producer of many clinically useful antibiotics. 
Rhodococcus has a diverse range of metabolic abilities such as degrading environmental 
pollutants and producing intermediates used for synthesizing compounds. Different species may 
produce different pigments and may have different colony appearances based on the species 
shown in figure 3. 
 
Figure 3: Strains of Rhodococcus on a wheel plate. Pigmentation and texture vary from species 
to species (Borisova 2011). 
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Industrial Biotechnology 
 Rhodococcus is useful for industrial biotechnology due to their ability to produce a 
variety of compounds such as flocculants, surfactants, amides, and polymers. They can degrade 
pollutants ranging from simple hydrocarbons to aromatic hydrocarbons, chlorinated polycyclic 
aromatics, and polychlorinated biphenlys (Bell et al. 1998). R. rhocochrous J1 is used in the 
synthesis of acrylamide, which is a chemical that is used in many industrial processes and is 
considered one of the most successful applications in using a microbial catalyst. Nitto Chemistry 
Industry Ltd in Japan uses the strain to produce over 30,000 tons of the chemical every year 
(Elsayed et al. 2017). Another use of Rhodococcus is the desulfurization of fossil fuels, which 
could improve fuel value and decrease the amount of sulfurous emissions from combustion of 
coal and petroleum (Bell et al. 1998). R. erythropolis is known to produce multiple enzymes that 
allow them to carry out several types of reactions such as hydrolysis, oxidations, 
dehydrogenations, desulfurizations, and hydroxylations have made them useful for multiple 
bioconversions and degradations (de Carvalho and da Fonseca 2005). The Rhodococcus genus’s 
diversity and ability to produce a wide variety of enzymes and compounds, as well as carry out a 
number of reactions make it very useful in the chemical industry.  
 
Pathogens 
 Members of the Rhodococcus genus are mostly non-pathogenic with only two strains 
playing a major role as pathogens in both plants and animals. R. fascians is a phytopathogen 
which is not known to cause human infections, but causes leafy gall disease in plants 
(Goodfellow, 1989). R. equi is the only known animal pathogen in the genus and can infect a 
22 
 
variety of animals but is most known for causing pneumonia in foals and other livestock. R. equi 
is an opportunistic pathogen, and can cause an infection similar to pulmonary tuberculosis in 
immunocompromised patients. Similar to Mycobacterium tuberculosis, R. equi infects 
macrophages, replicates in membrane-bound vacuoles and prevents maturation of the phagosome 
so the bacteria can proliferate inside of the macrophage (Majidzadeh and Fatahi-Bafghi 2018).  
 
Secondary Metabolites in Rhodococcus 
 Production of secondary metabolites in Rhodococcus have been observed. However, 
based on many newly sequenced genomes, Rhodococcus species often contain many different 
cryptic biosynthetic gene clusters.  This strongly suggests that this genus has the genetic 
potential to synthesize a large variety of secondary metabolites (Ceniceros et al. 2017). The first 
inhibitory molecule discovered from Rhodococcus was an antifungal molecule active against 
Candida albicans and identified in 1999 by Chiba et al. (1999). They identified five novel cyclic 
tetrapeptides: rhodopeptin C1, C2, C3, C4, and B5 shown in figure 4. These rhodopeptins have 
no antibacterial activity.  
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Rhodopeptin R1 R2 R3 R4 
Rhodopeptin 
C1 
CH3 NH2 CH3 CH3 
 
Rhodopeptin 
C2 
CH2-CH3 NH2 CH3 CH3 
 
Rhodopeptin 
C3 
CH3 NH2 H CH-(CH3)2 
Rhodopeptin 
C4 
CH3 NH2 H CH (CH3)-C2H5 
 
Rhodopeptin B5 CH3 CH2-NH2 H CH2-CH (CH3)2 
 
Figure 4: Structures of the antifungal Rhodopeptins C1, C2, C3, C4, and B5. (Elsayed et al. 
2017). 
 Iwatsuki et al. (2007) discovered the antimycobacterial peptides named laritin A and B. 
Laritin A was shown to inhibit Mycobacteruim tuberculosis. The peptides are produced by 
Rhodococcus sp. K01-B0171 and form a “lasso” structure. 
 Rhodostreptomycin A and B are two antibiotics that were described by Kurosawa et al 
(2008). These antibiotics are produced by Rhodococcus fascians 307CO after being grown in a 
coculture with a known antibiotic producer, Steptomyces padanus. R. fascians does not produce a 
known antibiotic, but the strain 307CO produces the rhodostreptomycins as a result of horizontal 
gene transfer from the Streptomyces bacteria. The rhodostreptomycin isomers differ from the 
actinomycins produced by the Streptomyces, and are active against a variety of different bacteria 
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like E. coli, S. aureus, B. sub, as well as S. padanus. Figure 5 shows the structure of 
rhodostreptomycin. 
 
Figure 5: The structure of Rhodostreptomycin (Elsayed et al. 2017). 
 
Rhodococcus sp. MTM3W5.2 
 Rhodococcus sp. MTM3W5.2 is a strain that was isolated from lawn soil in Morristown, 
Tennessee in 2011 (Borisova 2011). The bacteria was isolated using an M3 enrichment (heat 
shock) method and was discovered to produce a potent inhibitory compound active against other 
Rhodococcus species, including the zoonotic pathogen R. equi. The inhibitory molecule was 
discovered using a disk diffusion screen of agar culture extracts. The strain grows large, flat 
colonies with tan pigmentation at 22°C as shown in figure 6. The sequenced 16S rRNA gene 
shows a 99% match to that of R. mannshanesis (Ward et al. 2018)  
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Figure 6: MTM3W5.2 colonies and antibacterial activity. (A) MTM3W5.2 colonies appear large, 
flat, and have a tan pigmentation. (B) a disk diffusion assay showing the inhibitory molecule 
against an indicator strain (Ward et al. 2018). 
 
The Inhibitory Molecule  
 The inhibitory molecule produced by MTM3W5.2 is active against other Rhodococcus 
species and other closely related species, such as Corynebacterium and Gordonia, but is not 
active against other Gram positive or negative bacteria. The compound is only produced in 
stagnant cultures under 22°C. The entire structure of the compound has yet to be determined, but 
fragments of the compound that have been identified indicate a macrolide-like structure. The 
compound has a molecular weight of 911.5490 m/z and a chemical composition of C52H70O13. 
The gene responsible for this antibiotic was discovered by generating non-producing mutants 
with random transposon insertional mutagenesis with the transposon pTNR (Ward 2015). Two 
nonproducing mutants, 2.31 and 77.23 were identified, and the biosynthetic gene cluster 
responsible for producing the antibiotic was discovered when the entire genome of the producer 
strain was sequenced. The cluster indicates several type I polyketide synthases that are 
presumably required to produce the compound shown by the blue arrows in figure 7. Gene 
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BTZ20_3964, the green arrow in the figure lies at the beginning of the gene cluster, is believed 
to be the regulator of the cluster. 
 
Figure 7: Biosynthetic gene cluster responsible for the inhibitory molecule. Blue arrows are type 
I PKS genes, green arrow in a transcriptional regulatory gene, red arrows are NRPS type genes, 
and brown arrows are other gene classes. RMP 77.23 and 2.31 designate the pTNR transposon 
insertion location to produce a nonproducing mutant. BTZ20_3964 is believed to be a positive 
regulator of the gene cluster (Ward et al. 2018). 
 
Current Work 
 Rhodococcus is an underexplored and potential source of new antibiotics. Genomic 
sequencing indicates that there are a variety of BCGs within the genome of many Rhodococcus 
species, but the function of the majority of these products are unknown and appear to be 
produced under cryptic pathways. The gene BTZ20_3964 is believed to be a positive luxR solo 
type regulator of the gene cluster. For my project, I hypothesized a deletion of this gene from the 
genome would render a mutant strain no longer able to produce the inhibitory compound. I also 
hypothesized that this gene can be cloned into a high expression vector and complement the non-
producing mutant, which should restore production of the compound, but may also boost 
production or awaken other cryptic pathways in the cell.  
27 
 
CHAPTER 2 
MATERIALS AND METHODS 
Bacterial Growth Media 
Lysogeny Broth Medium (LB) 
This medium was prepared by combining the following components. The following 
amounts are for every 500mL of distilled H2O: 
1. Tryptone 5g 
2. Yeast 
Extract 
2.5g 
3. NaCl 5g 
4. dH2O 500mL 
5. Bacto Agar 7.5g 
LB plates with 10% sucrose are made by excluding NaCl and adding 50g of sucrose per 
500 mL of media.  
 
Rich Media (RM) 
This medium was prepared by combining the following components. The following 
amounts are for every 500mL of distilled H2O: 
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1. Glucose (Dextrose) 5g 
2. Nutrient Broth 4g 
3. Yeast Extract 0.25g 
4. Bacto Agar 
 
7.5g 
5. dH2O 500mL 
 
Mueller-Hinton Medium (MH) 
MH plates were made by adding 19.5g of Difco™ Mueller0Hinton Agar to 500 mL of 
dH2O. The mixture was boiled to mix the ingredients and autoclaved, then cooled in a 55°C 
water bath. Once cooled, the agar was poured into sterile Petri dishes. 
MH broth was prepared by adding 11g of BBL™ Mueller-Hinton Broth to 500 mL of 
dH2O. The mixture was boiled to mix and autoclaved.  
 
Bacterial Strains 
The strain Rhodococcus sp. MTM3W5.2 was used as the wild type strain that produces 
the inhibitory compound. E. coli DH5α was used for plasmid isolation of pEX18km and 
pEX18kmAD3964 for transformation into Rhodococcus sp. MTM3W5.2 to create the 
merodiploids. E. coli DH5α was inoculated on LB medium and incubated at 37°C overnight.  
Rhodococcus MTM3W5.2 was inoculated into RM or LB medium and incubated in a 28°C water 
bath for 24 hours. Kanamycin was added to the medium at a concentration of 200-400 µg/mL 
when used for selection. RM slants of the parent strain, merodiploids, and mutant strains were 
made and stored at 4°C.  
29 
 
Bacterial Seed Cultures 
Seed cultures were prepared by inoculating a pure Rhodococcus MTM3W5.2 colony in 
2mLs of RM broth and incubating in a shaking water bath at 28°C for 1-2 days. Seed cultures 
were used for genomic DNA isolation, RNA isolation, and preparation of electro-competent 
cells. E. coli seed cultures were inoculated into LB and grown at 37°C overnight. 
 
Genomic DNA Isolation from Rhodococcus Cells 
A 2 mL LB broth seed culture (with Kanamycin200 µg/mL if isolating merodiploids) was 
prepared and incubated in a 28°C water bath shaking overnight. 0.5 mL of the seed culture was 
used to inoculate 25 mL of LB broth (with antibiotic if necessary) in a 250mL flask with a cotton 
stopper and incubated at 28°C in a shaking water bath at least 24 hours. 200 µg of ampicillin 
from a stock of 50 mg/mL was added to the flask (final concentration around 8ug per mL), and 
the culture was allowed to incubate in the 28°C water bath while shaking. After 24 hours, 10-15 
mL of the culture was placed in a sterile Oakridge tube, and spun to pellet the cells. The 
supernatant was discarded, and the cells are washed in 10 mL of 1X TE buffer. Cells are pelleted 
again and supernatant was discarded. The pellet was resuspended in 1 mL of TES buffer and 1 
mL of 1X TE buffer with 50 µg of fresh lysozyme. The cells were incubated at 37°C for at least 
4 hours while shaking. 500 µL of the mixture was then added to sterile 1.5 mL microfuge tubes. 
30 µL of 20% SDS was added to each tube and tubes are inverted to mix. 10 µL of RNase (33 
µg/mL) was added to each tube, mixed by inverting, and incubated at 55°C for 15 minutes. 10 
µL of proteinase K (20 µg/mL) was added to each tube, mixed by inverting, and incubated at 
55°C for 15 minutes. A phenol-chloroform extraction was performed on each tube. 500 µL of 
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phenol was added to each tube and mixed by inverting, the tubes are spun, and the top layer was 
collected to a new tube. Two chloroform-isoamyl extractions are performed on each tube by 
adding 500 µL chloroform-isoamyl (24:1), mixing by inverting, spinning and transferring the top 
aqueous layer to a fresh tube. To the final tube, add 1 mL of cold 100% ethanol and mix by 
inverting. The chromosome would then precipitate and clot. The chromosome was spooled with 
a pipet tip and transferred to a new 1.5 mL microfuge tube containing 400 µL of 70% ethanol. 
The tube was spun for 1 minute and the ethanol was aspirated. The chromosome is allowed to 
briefly air dry, then was re-dissolved in 100 µL of 0.1 TE and stored at 4°C. 
Genomic DNA Isolation Solutions 
1X TE Buffer  
     5 mL 1M Tris-HCL, pH 7.5 
     1 mL 0.5 M EDTA, pH 8.0 
     499 mL ddH2O 
 
TES Buffer  
     9.8 mL 50 mM Tris, pH 8.0 
     20 µL 0.5 M EDTA 
     213 µL 40% Sucrose 
 
Deletion of the gene BTZ20_3964 
 The postulated luxR solo gene, BTZ20_3964, was deleted from the chromosome of strain 
MTM3W5.2 by the method of “overlap extension PCR” (Heckman and Pease 2007). Here a set 
of four primers; 3964-A, 3964-B, 3964-C, and 3964-D, were designed such that primers 3964-A 
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and 3964-B amplify about 1119 bp of flanking DNA upstream of the gene BTZ20_3964 and 
primers 3964-C and 3964-D amplify about 1045 bp of flanking DNA just down stream of the 
gene.  However, primers 3964-B and 3964-C are mutagenic primers that are complementary to 
each other and can produce a nearly complete deletion of the 3964 gene.  The deletion construct, 
3964-AD, was produced when the amplified DNAs 3964-AB and 3964-CD are mixed and 
annealed together at their 3’-ends (their 3’-ends are complementary due to the presence of the B 
and C primers and can base pair together) (Fig. 8).  This produces a template DNA that can be 
amplified in a final PCR reaction to give the deletion construct 3964-AD. This DNA contains 
about 1kb of both upstream and downstream flanking DNA sequence, but a nearly complete 
deletion (only 164 out of 2,790 bp remain) of the BTZ20_3964 gene (Fig. 8). 
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Figure 8. (Continued on next page) 
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3964-A: 5’- ATGGATCCAGAGAAGGCACAACCGCTA 
3964-B:  5’- GTCAGGTGCTGCTCAGATATCTCCCCGAAC 
3964-C:  5’-GTTCGGGGAGATATCTGAGCAGCACCTGAC 
3964-D: 5’-TCAAGCTTAGCACACCGGCGATAATGAA 
Figure 8.  Primer design for overlap extension PCR.  Blue highlighted sequence is the beginning 
(TTG start codon) and end (TGA stop codon) of the gene BTZ20_3964 (dots represent large 
missing region of gene). Solid underlined sequences are primers “A” and “D”.  The mutagenic 
primers “B” and “C” are underlined with a solid line beginning with a black dot and ending with 
an arrow.  Sequences underlined with a dashed line are internal primers used to detect the deleted 
copy of the 3964 gene in the chromosome of MTM3W5.2. 
 
Creation of Deletion Construct pEX18km3964AD 
The suicide vector pEX18Gm as described by Hoang et al. (1998 ) was used to create the 
deletion construct. In the plasmid pEX18Gm, the gentamycin resistance marker was replaced 
with a kanamycin resistance gene at the restriction enzyme sites EcoRV and SspI ,via blunt 
ligation to create pEX18Km (Fig.14). Both 3964AD (PCR)DNA and pEX18Km plasmid DNA 
were digested with the restriction enzymes BamHI and HindIII, and ligated together to create the 
deletion construct pEX18Km3964AD (Fig.14).  
 
Plasmid Isolation 
 Plasmids pEX18km, pEX18km3964AD, and pDD57 were transformed into E. coli DH5α 
and isolated using a protocol described by Ward (2015).  
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Preparation of Electro-Competent Cells 
For Rhodococcus MTM3W5.2 electro-competent cells, a 2 mL seed culture in RM broth 
was incubated at 28°C overnight. 1 mL of the seed culture was used to inoculate 50 mL of RM 
broth in a 250 mL “side arm” flask. The initial density was measured with a Klett colorimeter. 
The flask was incubated in a 28°C water bath until a Klett reading of around 80 (red filter) was 
reached; this took about 48 hours. A loop of the culture was streaked out on an RM agar plate 
and incubated at room temperature for 4 days to check for contamination. The remaining culture 
was transferred to a 250 mL centrifuge bottle and set on ice for 5 minutes. The culture was 
centrifuged in a large rotor (FiberliteTM F14-6 x 250y Fixed-Angle Rotor, Thermo Scientific) at 
6,000 rpm for 7 minutes at 4°C. The supernatant was discarded and using a pipet, the pellet was 
resuspended in 30 mL of ice cold 10% glycerol and left to rest on ice for 10 minutes. The 
centrifuge conditions were repeated and the supernatant was discarded. Again using a pipet, he 
cell pellet was resuspended in 15 mL of ice cold 10% glycerol and transferred to an Oakridge 
tube and iced for 10 minutes. The centrifuge was repeated with the same conditions in a small 
rotor (FiberliteTM F14-6 x 50cy Fixed-Angle Rotor, Thermo Scientific). The supernatant was 
discarded and the cells are resuspended in 2.5 mL of ice cold 10% glycerol. The centrifuge was 
repeated, and the supernatant was discarded and the pellet was resuspended in 600 µL of ice cold 
10% glycerol. It is important to use a smaller pipette volume here to avoid generating bubbles. 
100 µL aliquots of the resuspended cells are transferred to 0.5 mL microfuge tubes and stored at 
-70°C.  
 
For E.coli electro-competent cells, an overnight seed culture of E. coli DH5α in 10 mL of 
YENB broth (0.75% yeast extract, 0.8% nutrient broth) was grown at 37°C. 5-10 mL of the seed 
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culture to inoculate 250 mL of YENB broth in 500 mL flask and incubated shaking until a Klett 
reading of 40-45 (red filter) was reached, about 5 hours. Centrifuge conditions are 4000xg for 10 
minutes at 4°C.  25 mL for cold sterile water are used for the first two washes, and 5 mL and 1 
mL of 10% glycerol are used for the second two centrifuges. Aliquots of 110 µL are transferred 
to 0.5 mL tubes and stored at -70°C.  
 
Creation of the Merodiploids 
Merodiploids of Rhodococcus MTM3W5.2 are created by transformation of the deletion 
construct pEX18km3964AD into electro-competent MTM3W5.2 cells via electroporation. 
Electro-competent MTM3W5.2 cells and the pEX18km3964AD plasmid prep are chilled on ice 
to allow to thaw. UV sterilized electroporation curvettes (Fisher Scientific, 2 mm width, 400 µL 
volume) are set on ice while the cells thaw. 2 µL of the plasmid DNA was added to the 
competent cells, and the total volume was pipetted into the sterile curvettes, taking care to avoid 
bubbles. The cells are electroporated at 2,500 volts (V). The pulse time was recorded; between 3-
5 seconds is ideal.  If the pulse time was outside of this range, or if the cells “pop”, the cells are 
discarded and the electroporation was repeated with new cells. 400 µL of RM broth was added to 
the transformed cells and transferred to a sterile test tube. The cells are incubated in a 28°C water 
bath for 3-5 hours while shaking. After incubation, cells are plated undiluted on LB Kan200 and 
LB Kan400 plates. The plates were incubated at room temperature until colonies appear, around 
5-7 days.  Colonies were transferred to wheel plates with the same kanamycin concentration. 
Controls with cells transformed with no DNA were done, and spontaneous mutants or 
background colonies were often observed on plates with a kanamycin concentration under 200 
µg/mL, so a higher concentration was used for selection. The wild-type gene is 2,793 base pairs. 
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The amplicon for the internal 3964 primers in the wild-type gene used is about 2,800 base pairs, 
while the amplicon using the same primers with the fragment AD will be much smaller at about 
220 base pairs and should run farther on a gel when used to screen for the deletion construct with 
PCR.  
 
Mutant Wheels 
After possible mutant colonies are plated on a wheel plate (Fig. 9), the plate was allowed 
to grow at room temperature for at least 2 days. The plate was then stored at 4oC and the strains 
should remain viable for years if the plate does not dry out.  Colonies that produced adequate 
growth were labeled and used to screen for the presence of the pEX18km3964AD deletion 
construct.  
 
Figure 9: A mutant wheel of transformants. Single colony transformants are streaked on a plate 
with antibiotic. No more than 16 mutants are placed on a single wheel.  
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Screening for Merodiploids 
Single colony PCR was used to screen for the presence of the pEX18km3964AD 
construct via a single cross-over recombination with either the upstream or down stream flanking 
regions of the BTZ20_3964 gene. A single colony (or equivalent cells) was suspended in PCR-
H2O and used as a DNA template for the PCR reaction. The primers pTNRKan left (5’-
TAGCTTGCAGTGGGCTTACAT) and pTNRKan right (5’-
TTCAGCAATATCACGGGTAGC) were used first to confirm the presence of the kanamycin 
resistance gene. Any colonies that have a kanamycin resistance gene was then screened with the 
primers for the sacB gene (sacB left (forward) 5’GGAAGGCAGTACACCTTGATAG-3’,sacB 
right (reverse) (5’GCTCTCCTGAGTAGGACAAATC-3’) and internal gene 3964 primers 
(3964internal left: 5’-CTGAGGACCTACGAGTGCAT-3’ and 3964 internal right: 5’-
AATCTCCTTGCGGCGGCCAGATA-3’). Alternatively, the Kan gene was screened for by 
plating potential mutants on LB plates with a 400µg and an 800µg kanamycin disk to look for 
resistance to kanamycin. Mutants showing resistance to both disks are screened using PCR for 
the kan gene, sacB gene, and the 3964 internal primers. A merodiploid should have 2 bands 
present for the 3964 internal primers; the larger, wild-type gene 3964 and the smaller, deleted 
AD3964 from the deletion construct. Colonies that showed all of the desired bands were selected 
as potential merodiploids and streaked on an RM slant and plated on LB Kan200 plates to 
maintain selection.  To determine if the merodiploid was an illegitimate recombinant where a 
single crossover event has occurred in an area of the chromosome which was not the region of 
homology adjacent to the gene 3964, 4 primers were created to screen for the location of the 
inserted plasmid. The primers amplify the regions outside of the flanking regions of gene 3964 
and a region internal to the gene. If the plasmid inserts into one of these flanking regions, the 
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amplicon from these primers should be very large (about 9 Kb) or maybe too large to amplify 
with the PCR conditions used to screen for the merodiploids. Primer sequences are as followed. 
3964newABprimer left 5’-TCTTGCCGGTTGTTAGTCCT-3’ 
3964newABprimer right 5’-CACCTTACGAGCAATGTCCG-3’ 
3964newCDprimer left 5’-TGCCACTGAAGGTACGGATT-3’ 
3964newCDprimer right 5’-GGTTCGCGCTCAATCTTCTC-3’ 
 
Figure 10: Location of new AB primers. Location of primers for amplification of the upstream 
flanking region of gene BTZ20_3964 for merodiploid legitimacy testing. Yellow highlighted 
sequences are primers 3964 NewABprimer left and 3964 New AB primer right.  Blue 
highlighted sequence in the 3964 ORF sequence. Underlined sequences are the old primers used 
to create the AB region of homology for overlap extension PCR. 
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Figure 11: Location of new CD primers. Location of primers for amplification of the 
downstream flanking region of gene BTZ20_3964 merodiploid legitimacy testing. Underlined 
sequences are the primers used to create the CD homology region for overlap extension PCR. 
 
The PCR program (named “Tom1”) was used for Promega’s Gotaq Flexi polymerase and was 
used to screen for these genes. The program is as follows  
1) 95°C 5 minutes 
2) 95°C 1 minute 
3) 55°C 1 minute 
4) 72°C 2 minutes 
5) Steps 2-4 repeated (x29) 
6) 72°C 5 minutes 
7) 4°C Hold 
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Screening for the Double Crossover Recombination Event 
Merodiploids are preserved on plates with kanamycin to maintain selection. A single 
colony was selected, and the merodiploids are grown in LB broth with no kanamycin to 
encourage a double crossover event. These cultures were grown shaking in a 28°C water bath for 
2 days. Dilutions are plated on LB plates with 10% sucrose and no NaCl added. Dilutions of at 
least 1/1000 are used to get isolated colonies. Sucrose plates are used to counter-select the sacB 
gene. Colonies are selected from the LB sucrose plates and plated on replica patch plates to 
screen for the loss of the kanamycin resistance gene. Colonies with the loss of the resistance 
gene are selected and plated on LB plates and screened again with the same primers, pTNR Kan 
right and left, sacB right and left, and 3964 internal right and left. Double crossovers should 
retain the smaller deleted band for the 3964 internal primers but should lack all other bands. 
Double crossovers are screened for antibiotic production via agar extraction. 
 
Cloning BTZ20_3964 into pDD57 
The expression vector pDD57 (DeLorenzo et al. 2018) contains a high activity promotor 
that should allow for high expression of the 3964 gene in Rhodococcus and is used for 
complementing the non-producing mutants. The gene 3964 was amplified by PCR using the 
program “Phusion1”(for the phusion taq polymerase from New England Biolabs) and the primers 
BTZ20_3964left680 5’-TTGCTTAATTAACGGAGGCTGGGGAATCTAAT-3’ and 
BTZ20_3964right3854 5’- TATTGAATTCTTCCGTCCACACTGATCCA-3’ . The PCR 
reaction was ethanol precipitated and then digested with the restriction enzymes EcoRI-HF and 
PacI for 90 minutes at 37°C. The reaction was heat inactivated at 65°C for 20 minutes. The 
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expression vector, pDD57 was also digested with these enzymes in these conditions and was 
then gel purified after gel electrophoresis via electroelution. The digested PCR DNA (gene 3964) 
was ligated into the digested plasmid and the ligation reaction was transformed into 
electrocompetent E. coli (DH5α). Antibiotic production would be screened with agar extraction 
and disk diffusion assays (Ward 2015).  
“Phusion1”: Conditions for NEB Phusion (high fidelity) polymerase 
1) 98°C 30 seconds 
2) 98°C 10 seconds 
3) 67°C 30 seconds 
4) 72°C 30 seconds 
5) Steps 2-4 repeated  x29 
6) 72°C 9 minutes 
7) Hold at 4°C 
 
Amino Acid Sequence Alignments 
An amino acid multiple sequence alignment of the gene BTZ20_3964 was made with 
other luxR solo homologs to show areas of conservation using the program Clustal Omega 
(Sievers et al. 2011). The reference sequences are those described by Brotherton et al.(2018) and 
are listed in Table 2. 
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Table 2. luxR Amino Acid Sequences used for the Multi-Sequence Alignment (Brotherton et al. 
2018) 
 
 
  
Name Species Description Accession 
Number 
Streptomyces Streptomyces canus Putative LuxR family 
transcription regulator 
AKQ13286.1 
traR Agrobacterium tumefaciens Transcriptional regulator WP_012478148.1 
bjaR Bradyrhizobium 
diazoefficiens JCM 
Transcriptional activator 
protein 
Q89VI3.1 
luxR Aliivibrio fischeri ES114 Autoinducer-binding 
transcriptional activator protein 
AAW87995.1 
phzR Pseudomonas chlororaphis 
Transcriptional activator 
protein 
 
P54303.1 
lasR Pseudomonas aeruginosa 
PAO1 
transcriptional regulator AAG04819.1 
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CHAPTER 3 
RESULTS  
Gene BTZ20_3964 is a Possible luxR Solo Regulator 
The suspected regulatory locus BTZ20_3694 is a luxR solo regulator, meaning it possibly 
regulates expression of the inhibitory compound produced by MTM3W5.2 without a luxI type 
synthase. A map of the functional domains in the protein is shown in figure 12, part A. Based on 
a BLAST homology search, only two functional domains were revealed in this large 930 amino 
acid protein. The first 300 amino acids at the N-terminus show similarity to an ATP binding 
domain. About the last 300 amino acids at the C-terminus shows similarity to luxR regulatory 
proteins. A multiple sequence alignment of this C-terminal region with other luxR solo proteins 
was constructed using the program Clustal Omega using the reference sequences of a 
Streptomyces luxR solo and other solos from Proteobacteria as described by Brotherton et al. 
(2018). The gene BTZ20_3694 is 930 amino acids long, which is much larger than that of the 
other reference genes, so the alignment only shows the luxR solo region of the protein (Green 
hatched region, part A, Fig.12), which is composed of roughly the last 300 amino acids. Highly 
conserved amino acids in the luxR solo proteins found among the Proteobacteria are highlighted 
in yellow (part B, Fig.12) and is based on the analysis of Brotherton et al. (2018).  The 
Rhodococcus luxR solo is more closely related to the Streptomyces regulator than the reference 
Proteobacteria homologs. According to Brotherton et al. (2018), the amino acids at the positions 
labeled “1” and “2” (part B, Fig. 12) are conserved among all the Proteobacteria luxR solos but 
differ in these proteins found in the Actinobacteria.  Indeed, the conserved tryptophan at position 
labeled “1” is instead an alanine in both the Streptomyces and Rhodococcus luxR proteins. 
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Figure 12:Multiple sequence alignment and map of gene 3964. A: A map of the 3964 
protein domains. The luxR solo region is shown in green hatching.  Green arrow 
designates region of the protein in the sequence alignment in part B. B: A multiple 
sequence alignment of the 3964 gene with that of other luxR solo homologs made with 
Clustal Omega. Reference sequences are listed in table 2. Positions 1 and 2 mark the 
locations where the Actinobacteria proteins are described to differ from the 
Proteobacteria (Brotherton et al., 2018). This is within the conserved autoinducer 
binding domain of luxR regulatory proteins. 
 
Creation of the Deletion Construct pEX18Km3964AD 
In the first set of PCR reactions, flanking DNA upstream (DNA “AB”, Fig.13) and 
downstream (DNA “CD”, Fig.13) were amplified.  Then DNAs AB and CD were annealed 
A 
B 
1  2 
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together at their 3” ends and extended (Fig. 13).  The AD fragment, containing the deleted 
version of the 3964 gene was cloned into the plasmid pEX18km and the map was show in figure 
14. The kanamycin resistant marker can be used to select for the merodiploid and the sacB gene 
can be used for counterselection to obtain a double-crossover mutant. 
  
Figure 13: Creation of the 3964AD gene via PCR-overlap extension 
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Figure 14: Map of the deletion construct pEX18Km3964AD 
 
Creation of the MTM3W5.2 Merodiploids with pEX18km3964AD 
 The suicide vector pEX18km was used to introduce the deletion construct 3964AD into 
the Rhodococcus genome in order to generate a merodiploid. The plasmid does not contain an 
origin of replication for Rhodococcus, so it cannot replicate in MTM3W5.2 and allow the 
bacteria to grow on a kanamycin plate unless a single crossover occurs and the deletion construct 
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inserts into the genome. Figure 15 part “A”: shows the single crossover recombination event to 
give a merodiploid of the 3964 gene. 
 
 
Figure 15: Diagram of the single and double crossover recombination events. In the single 
crossover “A”, the plasmid with the deletion construct inserts into the MTM3W5.2 genome in 
regions flanking the 3964 gene to make the merodiploid. In part B, a double crossover occurs to 
replace the functional 3964 gene with the deleted version. The kanR gene and sacB gene are also 
lost from the genome.  
B 
A 
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Plating dilutions of the transformants on LBKan50 plates yielded a high number of 
background colonies that grew on the control plate that had no DNA added to the transformation, 
so the concentration of antibiotic used for selection was increased. Despite increasing the 
antibiotic concentration for selection to 400µg/mL, background colonies still appeared on control 
plates with no DNA after 6-8 days, but the numbers were reduced from the lower antibiotic 
concentration plates. The parent strain Rhodococcus MTM3W5.2 was susceptible to kanamycin 
at these concentrations, but would, apparently, produce spontaneous mutants that can grow on 
kanamycin plates. Transformants were plated undiluted on either RM Kan400 or LB Kan
400
 plates 
to increase the yield of merodiploids. Colonies that appeared on plates varied from 3 colonies to 
30 colonies per plate and were screened with PCR using the primers to test for merodiploids. 
Over 200 colonies were screened with the majority of transformants appearing negative for the 
kanamycin resistance gene. Transformants sometimes tested with a combination of positive 
results such as having the kanR gene, and the sacB gene, but only a deleted or functional copy of 
the 3964 gene, but not both genes (data not shown).  Confusingly, some transformant colonies 
having a kanR gene had one or both copies of the 3964 gene but lacked the sacB gene. 
Chromosome DNA was isolated from these mutants to test the PCR again with the same results.  
From this transformation, one transformant tested positive for all 4 desired genes, kanR, 
sacB, and both the functional and deleted 3964 genes (shown in figure 16, lane 8). This mutant 
was designated MTM3W5.2_1802 and was used to screen for a double crossover and deletion of 
the functional BTZ20_3964 gene. In all PCRs where any potential merodiploid was screened and 
contained both bands for gene 3964, one band was fainter than the other, often the functional 
3964 band.  
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Figure 16: Gel electrophoresis showing primers for merodiploid screening. A gel showing PCR 
DNA amplicons from the 3 sets of primers, sacB, KanR, and the internal 3964 primer. Lane 1, 
λHindIII molecular weight marker.  Lane 2, MTM3W5.2 as template DNA plus 3964 internal 
primers. As expected these primers only amplify the intact gene (~3Kb) but do not amplify the 
deleted version (~220bp). Lanes 3-5, plasmid pEX18Km3964AD as template DNA with primers 
for the sacB gene (lane 3), the kanamycin gene (lane 4) and the deleted version of the 3964gene 
(lane 5).  Lanes 6-8, MTM3W5.2-1802 strain as template DNA with primers for the sacB gene 
(lane 6), the kanamycin gene (lane 7), and the internal primers for the 3964 gene (lane 8).  
 
Counterselection of Double Crossovers with sacB 
 The pEX18km3964AD plasmid contains sacB, which was used for counterselection of 
mutants that still contain the gene. The merodiploids are grown in non-selective broth to 
facilitate a double crossover allelic exchange where AD (the deleted version of the 3964 gene) 
would replace the functional 3964 gene, and the kanR and sacB genes would also be lost (part 
“B”, Fig.18). Plating on LB + 10% sucrose plates did not show any discernable decrease in 
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colonies compared to the LB plates, indicating that sacB may not be an efficient counterselection 
method in Rhodococcus. Regardless of this, colonies from the LB+ 10% sucrose plates are plated 
on replica patch plates as shown in figure 17 to screen for the loss of the kanR gene. Few mutants 
showing loss of the kanR gene are observed during the initial round of selection, but selecting a 
patch from the kanamycin plate in the replica patch plates and growing again for 2 days in non-
selective broth would yield more mutants with the loss of the kanR gene. Screening of these 
potential double crossovers showed the kanR gene was lost along with the sacB gene, but the 
deleted 3964 gene construct was also, surprisingly, lost as well, indicating the plasmid was lost 
from the genome instead of a double crossover to replace the functional gene shown in figure 18. 
Multiple rounds of this experiment was performed altering the amount of time the bacteria were 
allowed to grow before plating on the sucrose, but the result was always that the plasmid was lost 
from the genome but the intact parental copy of the 3964 gene was retained (Fig.18, lanes 5-16).  
 
 
 
 
 
 
 
 
Figure 17: Patch replica plates for double crossover screening. Patch replica plates on LB and 
LBKan400 from colonies on the LB+10% sucrose plates. Circles patch indicates a colony that 
appears to have lost the kanamycin resistance gene. 
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Figure 18: Gel picturing loss of the pEX18km3964AD plasmid from a potential merodiploid. Gel 
shows the potential merodiploid strain MTMW5.2_1802. PCR reactions used colonies (as DNA 
template) selected from the LB patch replica plate that has appeared to lose the kanR gene. Lanes 
are as follows: 1: λHindIII, 2:MTM3W5.2 colony as a DNA template with 3964 internal primers. 
3: pEX18km3964AD plasmid as DNA template with primers for the kanamycin resistance gene. 
4: pEX18km3964AD plasmid as template with 3964 internal primers. 5:  MTM3W5.2_1802 
colony from replica plates as DNA template with primers for the kanR gene. 6: MTM3W5.2_1802 
colony (replica plate) as template with 3964 internal primers. Lanes 7-16 are additional kanamycin 
sensitive colonies from the replica plates used as DNA template in similar PCR reactions.  Note 
that the kanR gene was indeed lost, but only the functional 3964 gene was retained, suggesting that 
the plasmid was lost instead of a double crossover taking place 
 
Testing Legitimacy of Merodiploids 
Despite the amount of times the replica patch plating was repeated or how many colonies 
were tested from MTM3W5.2_1802, the deletion construct was always lost instead of a double 
crossover occurring. There is a possibility of an illegitimate recombination in Rhodococcus 
(Desomer et al. 1991), where the plasmid inserts into the chromosome, but not into the 
homologous flanking regions of gene 3964. In this instance a double crossover to remove the 
Functional 3964 gene 
Deleted 3964 gene 
1   2    3     4    5    6     7    8   9   10  11  12  13  14  15  16 
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parental copy of the 3964 gene would not occur after growth and counter selection on sucrose 
plates. Primers were designed to amplify a site of the flanking region of gene 3964 and a site 
internal to gene 3964 to determine if the deletion construct was inserting into the flanking region 
(Fig. 19). If the plasmid inserts into the flanking region, the amplified region would be much 
larger (~9Kb) than the parental flanking region, or may be too large to amplify with the normal 
PCR conditions. The potential merodiploid MTM3W5.2_1802 was determined to be an 
illegitimate recombinant with these primers, as the plasmid did not appear to insert in the  
flanking regions of gene 3964 (Fig. 19, lanes 6-14)  
 
Figure 19: Gel screening for illegitimate recombinants. Gel shows PCR reactions from isolated 
genomic DNA from potential merodiploids. The flanking region amplicons should be a little 
over 1kb. If the pEX18km3964AD plasmid inserts into a flanking region, the amplicon should be 
over 9kb, and would run a little below the second band on the HindIII marker. The lanes are as 
followed using a 1/10 dilution of genomic chromosome as the DNA template: 1: λHindIII, 2: 
MTM3W5.2- NewAB, 3: MTM3W5.2-NewCD, 4: pEX18km midi-AB, 5: peX18km midi-
NewCD, 6: MTM3W5.2_1800-NewAB, 7: MTM3W5.2_1800-NewCD, 8: MTM3W5.2_1801-
NewAB, 9: HindIII, 10. MTM3W5.2_1801-NewCD, 11: MTM3W5.2_1802-NewAB, 12: 
MTM3W5.2_1802-NewCD, 13: MTM3W5.2_1803-NewAB, 14: MTM3W5.2_1803-NewCD. 
All potential merodiploids tested did not appear to have the plasmid inserted into the flanking 
regions. 
1   2   3   4  5  6   7   8   9  10 11 12 13 14 
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CHAPTER 4 
DISCUSSION 
With the rise of multiple antibiotic resistant pathogens, the urgency to discover new 
antibiotics has increased. Only one new class of antibiotic has been discovered and approved for 
clinical use in decades, but bacteria are developing multi-drug resistance at an alarming rate. 
Finding new antibiotics is necessary to treat these pathogens, but is a difficult task due to the low 
culture rate of microbes and the large number of possibly therapeutic secondary metabolites 
being produce under a cryptic pathway in vitro. In order to discover new antibiotics and avoid 
high rediscovery of old antibiotics, underexplored sources need to be examined. Rhodococcus is 
known for its production of bioactive metabolites that have a wide range of activities which 
makes it useful in the biotechnology industry. Rhodococcus is a relative of Streptomyces, the 
biggest producer of our clinically used antibiotics, and has been shown to produce some 
antimicrobial molecules such as the rhodopeptins, laratins, and rhodostreptomycins. 
Rhodococcus is underexplored as a source of antibiotics, but genomic sequencing of the species 
indicates a large number of PKS and NRPS genes which could indicate a gene cluster that 
produces an inhibitory molecule, and Rhodococcus remains a potential source of new antibiotics 
(Ceniceros et al. 2017).  
 
Gene BTZ20_3964 as a Possible luxR Solo Regulator 
Many secondary metabolites may be controlled under quorum sensing systems due to the 
high cost of many metabolites. Secondary metabolites such as siderophores and inhibitory 
molecules cost the bacteria a lot of resources to produce, so it is not always efficient to have 
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these pathways permanently expressed. This is part of the reason why it can be difficult to find 
new antibiotics because they are often tightly regulated and may be produced poorly under 
laboratory culture conditions, or not at all. The inhibitory compound produced by Rhodococcus 
strain MTM3W5.2 is only produced in stagnant broths or on agar plates at temperatures below 
22oC (Ward et al. 2018). These strict conditions for expression may be due to the presence of a 
regulator gene at the start of a biosynthetic gene cluster responsible for the production of the 
antibiotic. This potential regulator, gene BTZ20_3964, is likely a luxR solo regulator. A luxR 
solo regulator lacks a luxI type synthase (which normally synthesizes the autoinducer molecule) 
in the operon. Thus, a luxR solo may respond to some other type of signal molecule from internal 
or external sources (Brotherton et al. 2018). luxR regulators are not well defined in 
Actinobacteria, but a multiple amino acid sequence alignment of the BTZ20_3964 protein 
indicates many areas of conservation with other defined luxR solo regulators from 
Proteobacteria, but it shares more aligned amino acids with the luxR solo of its phylogenetic 
relative Streptomyces (Fig. 12). The source and nature of the signal molecule for this regulator is 
unknown, and could be either endogenous or exogenous. There is no luxI type synthase located 
in or close to the gene cluster responsible for producing this inhibitory compound, suggesting 
that the cluster is controlled by a luxR solo regulator. 
 
Transformation of MTM3W5.2 with pEX18Km3964AD 
 Transformation of Rhodococcus MTM3W5.2 proved to be challenging with inconsistent 
results. The time constant after electroporation was always within the acceptable range, fresh 
competent cells were regularly used, and incubation time was monitored at the correct 
temperature, but colony yield always varied. Initially, lower concentrations of Kanamycin (50-
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200 µg/mL) were used to select for the merodiploid, but even when plated at dilutions, a high 
number of spontaneous mutants would appear. Even at Kan200 µg/mL, a high number of colonies 
would appear on the control plates that were electroporated with no added DNA. Similar results 
are reported in a study performed by Fernandes et al. (2001); antibiotic concentrations under 400 
µg/mL yield a high number of spontaneous mutants in Rhodococcus. Additionally, the study 
suggests that plating the transformants immediately on non-selective solid media and adding the 
antibiotic with a concentration between 400-500 µg/mL after at least 12 hours produced a higher 
yield of colonies than plating on a selective agar after incubation of the transformants. A soft 
agar overlay containing the desired amount of antibiotic yielded a higher number of true 
transformants (Fernandes et al. 2001). These conditions were repeated for MTM3W5.2 and 
while they did decrease the spontaneous mutants when diluted, potential merodiploids isolated 
were also deemed illegitimate (data not shown), however the method could be promising for 
future transformations to create merodiploids.  
 
Insertion of the Deletion Construct into MTM3W5.2 
 In order to obtain a double crossover mutant where the deletion construct 3964AD 
replaces the functional BTZ20_3964 copy, the construct pEX18Km3964AD, which lacks an 
origin of replication in Rhodococcus must first crossover into the homologous flanking regions 
of the functional gene to create the merodiploid. Once the suicide vector recombines into the 
genome, the merodiploids can be selected for with kanamycin because of the resistance gene 
contained in the plasmid. Then, the merodiploids are grown in nonselective broth to allow a 
double crossover recombination event, where the deletion construct 3964AD replaces the 
functional gene, and the sacB and kanR genes are also lost. Sucrose plates are used to counter 
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select the sacB gene and any cells that have not had the double crossover event should not grow 
well on sucrose plates, but no significant decrease in the number of colonies on the sucrose 
plates from the control LB plates was observed. This may indicate that sucrose is not a very 
efficient counterselection agent for Rhodococcus strain MTM3W5.2; the sacB protein may not 
be efficiently expressed or may not be efficient in preventing growth of cells containing the gene 
in this species. Regardless, colonies taken from the sucrose plates were screened for the loss of 
the kanR gene, and it appeared that every loss of the gene indicated the loss of the entire 
pEX18Km3964AD plasmid, including the deletion construct, from the genome (Fig. 18, lanes 6-
16). Despite a double crossover being a rare event, repeating the test should eventually lead to a 
double crossover mutant, but regardless of how many times the experiment was repeated, the 
plasmid was always lost. This indicated that the plasmid may not have inserted into the flanking 
regions of the 3964 gene. In order to test this, primers were created to amplify each flanking 
region and a region internal to the functional 3964 gene. Insertion of the plasmid into one of the 
flanking regions should either increase the amplicon size of these primers, or may prevent 
amplification due to the large size of the amplicon. All potential merodiploids isolated appeared 
to have intact flanking regions, i.e., the same size as the parental flanking regions (Fig.19, lanes 
6-14), meaning the plasmid inserted somewhere else in the genome and would not be able to 
complete a double crossover to remove the functional 3964 gene from the genome. 
 
Illegitimate Recombination in Rhodococcus 
Illegitimate recombination of Rhodococcus has been observed in previous studies. In a 
study performed by Desomer et al. (1991), a plasmid that cannot autonomously replicate in R. 
fascians would, instead, stably insert into the bacterial chromosome at, roughly, random 
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locations.  However, the plasmid has a specific DNA sequence site where it recombines with the 
chromosome; specifically at the plasmid sequence …CCGCANNNGGCGCC…  The locations 
in the chromosome where the plasmid inserts are not related to this plasmid sequence and are 
thus a form of illegitimate recombination.  The DNA sequence “GGCGCC” is found in two 
locations in the plasmid (pEX18Km3964AD) used for targeted gene deletion in strain 
MTM3W5.2.  One is found within the kanamycin resistance gene and the other is found in the 
“A” DNA in the upstream flanking region.  Neither of these “GGCGCC” sequences are preceded 
by the conserved “CCGCA” sequence, so it is unknown if this form of illegitimate 
recombination is occurring here.   
Unfortunately, this aberrant recombination event can not be avoided, and in order to find 
a true merodiploid with the pEX18Km3964AD plasmid inserted into the correct (homologous) 
region, screening of all merodiploids would have to be done in order to find one with the plasmid 
inserted into the flanking regions of the functional gene. It is unknown why a varying 
combination of the genes from the pEX18Km3964 plasmid appears to be inserted into some of 
the potential merodiploids, such as when the mutant has two copies of the 3964 gene, a kanR 
gene, but no sacB gene.  This may indicate insertion of part of the plasmid, or a recombination 
event taking place that removes some of the plasmid from the genome. When a gene is missing, 
but the others are present, the PCR reaction is repeated to confirm the results. If the plasmid 
inserted into the flanking region of gene 3964, but either the sacB or kanR gene was lost, it would 
be difficult to select/counter-select for these genes, but it could be possible for a double 
recombination event to replace the functional 3964 gene to occur, so any of these merodiploids 
that appears to have the partial plasmid inserted into the targeted region should be saved for later 
testing.  
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Future Works 
For future works, a true merodiploid must be obtained to facilitate the double crossover 
event and replace the functional gene 3964 from the genome to determine if the gene is a 
regulator of the inhibitory compound. Future transformations using the current deletion construct 
and a soft agar overlay on a nonselective plate may prove promising for recovering a true 
merodiploid. Alternatively, a process described by Sawitzke et al. (2007) as “recombineering” 
could be used to create the deletion construct and create a mutant strain of MTM3W5.2 
containing a nonfunctional copy of gene 3964. The in vivo process uses bacteriophage λ 
homologous recombination proteins that are collectively known as “Red”. The proteins only 
require about 50 bases of homology for recombination, making it a simple and efficient method 
and can use linear PCR products or single-stranded oligos. The process requires competent cells 
that contain the required proteins for the type of recombination, transformation with the DNA 
construct, and requires a selectable and counter selectable marker, commonly an antibiotic 
resistance marker and the sacB gene. This method could provide a more efficient way to recover 
true merodiploids in future works, but it would require the λ phage recombination proteins to be 
expressed in Rhodococcus and for the competent Rhodococcus cells to be transformed with the 
linear DNA construct. It is unknown how efficient this process would be in Rhodoccoccus. 
Another possible method for obtaining a mutant strain with a nonfunctional BTZ20_3964 gene 
would be using the CRISPR-Cas9 system to engineer bacterial genomes as described by Cho et 
al. (2018). Success in genomic engineering has been observed with members of the 
Actinobacteria including Corynebacterium and Mycobacterium, but it is unknown how efficient 
the process would be in Rhodococcus.  
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Once the true merodiploid is obtained, future projects would involve determining if the 
mutant lacking a functional 3964 gene produces the inhibitory compound. Once this is 
determined, and if the mutant is nonproducing, restoration of the inhibitory compound would be 
required to support gene 3964’s role as a regulator for the gene cluster. The plasmid pDD57 
containing a high activity promotor with the functional gene cloned in should complement the 
nonproducing mutant and restore production of the compound. Due to the high activity 
promotor, production of the compound may be increased or become unrestrictive. If higher 
quantities of the compound can be recovered, the entire structure may be identified. Additionally, 
it is possible that other cryptic pathways may be awaken by unrestricted production of the 
regulatory protein, and new novel products with unknown functions may be produced.  
An alternative theory to explain why a double crossover was not obtained may be that 
gene 3964 is an essential gene to Rhodococcus MTM3W5.2. Mutations to an essential gene are 
usually lethal and this may be a reason a mutant lacking gene 3964 was not generated. Secondary 
metabolites are not required for growth, and the regulator of a secondary metabolite would not 
normally be an essential gene, but it may be possible that this regulatory gene regulates a 
separate essential gene cluster located outside of the cluster responsible for producing the 
antibiotic compound. If a mutant lacking gene 3964 cannot be obtained through this or 
alternative methods, the role of this regulator as an essential gene may be investigated in the 
future.  
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